HHV-6 Encephalitis After Chimeric Antigen Receptor T-cell Therapy (CAR-T): 2 Case Reports and a Brief Review of the Literature
Open accessThe DOI matches its Crossref record; 54 of the 57 references it cites were found in a registry or an index.
Abstract
Human herpesvirus 6 (HHV-6) reactivation can occur in patients who are highly immunosuppressed, including those who have undergone hematopoietic stem cell transplantation (HSCT). HHV-6 encephalitis is a severe manifestation that is well described in the HSCT population. Chimeric antigen receptor T-cell (CAR-T) therapy is a novel cancer-directed immunotherapy that results in severe immunosuppression. Patients undergoing CAR-T therapy may be at risk for HHV-6 encephalitis, which can be difficult to distinguish from a common adverse effect of CAR-T therapy, neurotoxicity. Herein, we describe 2 patients diagnosed with HHV-6 encephalitis after CAR-T therapy and discuss the diagnostic approach and differential diagnosis for altered mental status after CAR-T therapy. Diagnosing HHV-6 encephalitis can be difficult in this patient population as altered mental status is common after CAR-T therapy and may be attributed to CAR-T-associated neurotoxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Serum HHV-6 quantitation can assist in differentiating active infection or reactivation; however, a high level does not consistently occur with CNS infection and can be isolated from otherwise healthy individuals (28).”
From A post-implementation evaluation of BioFire FilmArray Meningitis/Encephalitis panel for pathogen detection in cerebrospinal fluid with a special focus on clinical significance of HHV-6 (2026) · cites this paper as [28]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“the clinical symptoms remain nonspecific, including headache, delirium, and seizures (28)”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
Neelapu, S. S., Locke, F. L., Bartlett, N. L., Lekakis, L. J., Miklos, D. B., Jacobson, C. A., Braunschweig, I., Oluwole, O. O., Siddiqi, T., Lin, Y., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707447 · Cited by 6,030
Lee, D. W., Santomasso, B. D., Locke, F. L., Ghobadi, A., Turtle, C. J., Brudno, J. N., Maus, M. V., Park, J. H., Mead, E., Pavletic, S., et al. (2019) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2018.12.758 · Cited by 3,675
Tomblyn, M., Chiller, T., Einsele, H., Gress, R., Sepkowitz, K., Storek, J., Wingard, J. R., Young, J.-A. H., & Boeckh, M. A. (2009) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2009.06.019 · Cited by 1,797
Gust, J., Hay, K. A., Hanafi, L.-A., Li, D., Myerson, D., Gonzalez-Cuyar, L. F., Yeung, C., Liles, W. C., Wurfel, M., Lopez, J. A., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0698 · Cited by 1,400
Tunkel, A. R., Glaser, C. A., Bloch, K. C., Sejvar, J. J., Marra, C. M., Roos, K. L., Hartman, B. J., Kaplan, S. L., Scheld, W. M., & Whitley, R. J. (2008) · Clinical Infectious Diseases · doi:10.1086/589747 · Cited by 1,193
Santomasso, B. D., Park, J. H., Salloum, D., Riviere, I., Flynn, J., Mead, E., Halton, E., Wang, X., Senechal, B., Purdon, T., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-1319 · Cited by 942
Drobyski, W. R., Knox, K. K., Majewski, D., & Carrigan, D. R. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405123301905 · Cited by 345
Clinical Outcomes of Human Herpesvirus 6 Reactivation after Hematopoietic Stem Cell Transplantation
Zerr, D. M., Corey, L., Kim, H. W., Huang, M., Nguy, L., & Boeckh, M. (2005) · Clinical Infectious Diseases · doi:10.1086/428060 · Cited by 338
Post-transplant acute limbic encephalitis: Clinical features and relationship to HHV6
Seeley, W. W., Marty, F. M., Holmes, T. M., Upchurch, K., Soiffer, R. J., Antin, J. H., Baden, L. R., & Bromfield, E. B. (2007) · Neurology · doi:10.1212/01.wnl.0000265591.10200.d7 · Cited by 284
Human herpesvirus 6 limbic encephalitis after stem cell transplantation
Wainwright, M. S., Martin, P. L., Morse, R. P., Lacaze, M., Provenzale, J. M., Coleman, R. E., Morgan, M. A., Hulette, C., Kurtzberg, J., Bushnell, C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1251 · Cited by 222
Cited by
Infections after chimeric antigen receptor (CAR)‐T‐cell therapy for hematologic malignancies
Kampouri, E., Little, J. S., Rejeski, K., Manuel, O., Hammond, S. P., & Hill, J. A. (2023) · Transplant Infectious Disease · doi:10.1111/tid.14157 · Cited by 143
Shahid, Z., Jain, T., Dioverti, M. V., Pennisi, M., Mikkilineni, L., Kambhampati, S., Shah, N. N., Dadwal, S., Papanicolaou, G. A., Hamadani, M., et al. (2024) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2024.07.018 · Cited by 141
Iyer, S. P., Sica, R. A., Ho, P. J., Prica, A. A., Zain, J. M., Foss, F. M., Hu, B., Beitinjaneh, A., Weng, W., Kim, Y. H., et al. (2024) · The Lancet Oncology · doi:10.1016/s1470-2045(24)00508-4 · Cited by 128
Kampouri, E., Handley, G. H., & Hill, J. A. (2024) · Viruses · doi:10.3390/v16040498 · Cited by 37
Overview of infectious complications among CAR T- cell therapy recipients
Arya, S., & Shahid, Z. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1398078 · Cited by 34
Clinical features, pathophysiology, and management of acute myelopathy following CAR T-cell therapy
Deschênes‐Simard, X., Santomasso, B., & Dahi, P. B. (2024) · Blood · doi:10.1182/blood.2024025679 · Cited by 34
Neurotoxic complications of chimeric antigen receptor (CAR) T-cell therapy
Vonberg, F. W., Malik, I., O'Reilly, M. A., Hyare, H., Carr, A. S., & Roddie, C. (2025) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2024-333924 · Cited by 26
Kampouri, E., Krantz, E. M., Xie, H., Ibrahimi, S., Kiem, E. S., Sekhon, M. K., Liang, E. C., Cowan, A. J., Portuguese, A. J., Green, D. J., et al. (2024) · Blood · doi:10.1182/blood.2024024145 · Cited by 25
Spanjaart, A. M., van der Valk, F. M., van Rooijen, G., Brouwer, M. C., & Kersten, M. J. (2022) · New England Journal of Medicine · doi:10.1056/nejmcps2114818 · Cited by 25
Qian, H., Yang, X., Zhang, T.-T., Zou, P., Zhang, Y., Tian, W., Mao, Z., & Wei, J. (2024) · American Journal of Hematology · doi:10.1002/ajh.27198 · Cited by 15
Li, N., Zhang, R., Wang, J., Zhu, X., Meng, F., Cao, Y., Wang, G., & Yang, Y. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1334000 · Cited by 14
“However, two cases of human herpesvirus 6 B (HHV6B) encephalitis (10) and one case of HHV6B myelitis after CAR T cell therapy (11) have been previously reported.”
BackgroundInfluentialCAR T-cell therapy to treat multiple myeloma: current state and future directions
Reddy, S. T., Hosoya, H., & Mikkilineni, L. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-024-10219-1 · Cited by 13
Late events after anti-CD19 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma
Cordeiro, A., Durisek, G., Batista, M. V., Schmidt, J., Lima, M. J. G. D., & Bezerra, E. D. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1404351 · Cited by 12
Al‐Sadeq, D. W., Zedan, H. T., Al-Dewik, N. I. E., Elkhider, A. T. E., Hicazi, A., Younes, N., Ayoub, H. H., Abu-Raddad, L. J., Yassine, H. M., & Nasrallah, G. K. (2021) · IJID Regions · doi:10.1016/j.ijregi.2021.12.005 · Cited by 11
Meng, J., Ji, H., Chen, L., & Liu, A. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s379439 · Cited by 8
HHV-6 and HHV-7 reactivation in allogeneic CAR-T cell therapy
Chow, H. T., Li, W., Yang, B., von Wintzingerode, F., & Chen, Q. (2025) · Trends in biotechnology · doi:10.1016/j.tibtech.2025.03.017 · Cited by 7
Single-cell genomics-based immune and disease monitoring in blood malignancies
Rathgeber, A. C., Ludwig, L. S., & Penter, L. (2024) · Clinical Hematology International · doi:10.46989/001c.117961 · Cited by 5
Abad, C. L. R., & Razonable, R. R. (2025) · Frontiers in Virology · doi:10.3389/fviro.2025.1641157 · Cited by 5
CAR-T Cell Therapy and the Neurointensivist
Wijdicks, E. F. M., Rabinstein, A. A., & Lin, Y. (2024) · Neurocritical Care · doi:10.1007/s12028-024-01995-3 · Cited by 5
Perera, M., Varadhan, H., & Oon, A. (2026) · Microbiology spectrum · doi:10.1128/spectrum.00620-25 · Cited by 4
Human herpesvirus 6 viremia and encephalitis in CAR T-cell recipients
Isaac, S. T., Bishop, D. C., Shaikh, F., Micklethwaite, K. P., Gottlieb, D. J., & Blyth, E. (2025) · Blood · doi:10.1182/blood.2025029057 · Cited by 3
Mosunetuzumab-associated fatal HHV-6 encephalitis in a patient with follicular lymphoma
Samperio, V. M., Hamoud, M., & Dasanu, C. A. (2025) · Journal of Oncology Pharmacy Practice · doi:10.1177/10781552251355433 · Cited by 3
Extracellular viral microRNAs as biomarkers of virus infection in human cells
Chan, C. S. C., Loh, J. X. Y., Sin, W., Teo, D. B. L., Tan, N., Nagarajan, C., Chen, Y., Lim, F., Birnbaum, M. E., Williams, R. B. H., et al. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102444 · Cited by 2
Current status and perspective of off-the-shelf CAR-T cells in cancer immunotherapy
Fallahianshafiei, S., Babaeizad, A., Yang, P., La’ah, A. S., & Sheykhhasan, M. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.118986 · Cited by 2
Aftandilian, C. C., Bito, X. R., Berman, D., Zhang, C. A., Duttagupta, R., & Davis, K. L. (2024) · European Journal Of Haematology · doi:10.1111/ejh.14216 · Cited by 2
Li, B., & Keliang, C. (2026) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2026.07.005 · Cited by 1
Krishnan, M. S., DeBrock, V., Alali, M., Skiles, J. L., & Rahrig, A. (2026) · Pediatric Blood & Cancer · doi:10.1002/1545-5017.70300 · Cited by 1
Neurologic Complications of Cancer Immunotherapy
Balshi, A., Rajarajan, P., McEntire, C. R. S., & Manzano, G. S. (2026) · Seminars in Neurology · doi:10.1055/a-2936-4931
Human Herpesvirus 6A, 6B, 7, and 8 in Hematopoietic Stem Cell Transplant: A Clinical Review
Handley, G. H. (2024) · Springer eBooks · doi:10.1007/978-3-031-57369-9_14
Viral infections after allogeneic hematopoietic stem cell transplantation: Ongoing challenges
Ogata, M. (2024) · Japanese Journal of Transplantation and Cellular Therapy · doi:10.7889/tct-24-005
Encephalopathy Post CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma: Beyond ICANS
Ahmad, R. W., Wild, M., Friesen, T., Hall, M., Kouba, S., & Maliske, S. M. (2026) · Journal of Investigative Medicine High Impact Case Reports · doi:10.1177/23247096261478903
Birk, N. M., Kielsen, K., Met, Ö., Haastrup, E. K., Hulen, T. M., Madsen, C. O., Barington, T., Nielsen, J., Schønning, K., Petersen, S. L., et al. (2025) · Frontiers in Hematology · doi:10.3389/frhem.2025.1628552
HHV-6 reactivation in the era of CAR T-cell therapy: A systematic review of emerging challenges
Singh, P., Zaman, A., Hafeez, A. S., Faisal, A. R., Faizan, M., Qadri, H., Qureshi, A. J., Khan, M. A., & Khan, A. (2026) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2026.101222
Transplantation and Cellular Therapy in Lymphomas and Plasma Cell Disorders
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-5844-7
Piñana, J. L., Cesaro, S., Styczyński, J., Schmidt‐Hieber, M., Mikulska, M., Neofytos, D., Baccelli, F., Navarro, D., Onida, F., Ruggeri, A., et al. (2026) · EClinicalMedicine · doi:10.1016/j.eclinm.2026.104312
Acute Neurotoxicity Syndromes from Immunotherapy: Emergency and ICU Management
McEntire, C. R. S., Tschoe, C., Manzano, G. S., & Eckhardt, C. A. (2026) · Seminars in Neurology · doi:10.1055/a-2979-8424
Neurotoxicity of CAR T-Cell Therapy
Wijdicks, E. F. M., & Rabinstein, A. A. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780197676875.003.0030
Bovolenta, V., Cortez, A. C., Cordeiro, A., Schmidt-Filho, J., & Batista, M. V. (2025) · Blood Global Hematology · doi:10.1016/j.bglo.2025.100046
Li, N., Zhang, R., Wang, J., Zhu, X., Meng, F., Cao, Y., Wang, G., & Yang, Y. (2024) · doi:10.3389/fneur.2024.1334000.s001
Metadata
- Authors
- Rebechi, M. T., Bork, J. T., & Riedel, D. J.
- Affiliations
- University of Maryland, Baltimore (US)
- Corresponding author
- Rebechi, Melanie T
- Venue
- Open Forum Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-09-24
- Volume
- 8
- Issue
- 11
- Pages
- ofab470-ofab470
- ISSN
- 2328-8957 (ISSN-L)
- PMC
- PMC8562470
- OpenAlex
- W3204539237
- Cited by
- 37
- References
- 57
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 16 · 2023: 2 · 2022: 3 · 2021: 1
- FWCI
- 3.96
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Open Forum Infectious Diseases (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Health Sciences › Medicine › Infectious Diseases › Herpesvirus Infections and Treatments
- Keywords
- HHV-6 encephalitis, CAR T-cell therapy, immunosuppression, altered mental status, differential diagnosis, viral encephalitis, hematopoietic stem cell transplantation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.